Sandra M. Gurrola - 26 Apr 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Stock Option (Right to buy)	Award	$0	+80,000		$0.000000	80,000	26 Apr 2024	Common Stock	80,000	$1.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option shall vest in an initial installment of one-third on the one-year anniversary of the grant date, and the remaining shares shall vest in 24 substantially equal monthly installments thereafter.